tiprankstipranks
Trending News
More News >
Ingersoll Rand (IR)
NYSE:IR

Ingersoll Rand (IR) AI Stock Analysis

Compare
509 Followers

Top Page

IR

Ingersoll Rand

(NYSE:IR)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
$104.00
â–²(10.71% Upside)
Action:UpgradedDate:02/14/26
The score is driven mainly by solid fundamentals (healthy operating profitability and strong cash generation) and constructive technical momentum (price above key moving averages with positive MACD). This is tempered by a very high P/E and modest management guidance alongside noted near-term headwinds (tariffs, sub-1 book-to-bill, and slower long-cycle conversions).
Positive Factors
Operating profitability & cash generation
Sustained high operating margins and strong free cash flow provide durable internal funding for capex, R&D, and returns. FCF tracking ~0.9x net income and multiyear cash generation support resilience through cycles and enable strategic investments without sole reliance on external financing.
Recurring revenue acceleration & backlog
Growing recurring revenue and a sizable contracted backlog materially increase revenue visibility and stabilize cash flows. This recurring base raises lifetime customer value, supports higher margins over time, and cushions near-term organic volatility by converting contracted flows into predictable revenue.
Disciplined M&A execution and pipeline
A proven M&A program is expanding revenue and capabilities, adding ~ $275M inorganic revenue in 2025 while maintaining disciplined multiples. A deep pipeline plus recent tuck-ins accelerate scale, diversify end markets, and can sustainably lift growth above modest organic trends when integrated effectively.
Negative Factors
Rising leverage and weakening ROE
Debt increased materially into 2024–2025, reducing equity efficiency and pushing ROE lower. Higher leverage limits financial flexibility for large cyclical downturns, raises interest exposure, and increases the need for consistent cash generation to avoid pressure on credit metrics and strategic optionality.
Tariff-driven margin pressure & reinvestment
Tariffs and deliberate commercial reinvestment are compressing near-term margins and inflating costs. If sustained, these structural headwinds can erode net income and cash conversion, forcing either price increases (risking demand) or ongoing reinvestment that depresses profitability for multiple quarters.
Order conversion risk; book-to-bill <1
A book-to-bill below one and lengthening decision cycles create execution risk: a strong funnel may not convert to revenue timely, inflating backlog aging and pressuring near-term growth. Structural delays in long-cycle projects can reduce revenue visibility and delay return on invested capital.

Ingersoll Rand (IR) vs. SPDR S&P 500 ETF (SPY)

Ingersoll Rand Business Overview & Revenue Model

Company DescriptionIngersoll Rand Inc. provides various mission-critical air, fluid, energy, specialty vehicle and medical technologies in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services segment designs, manufactures, markets, and services various air and gas compression, vacuum, and blower products; fluid transfer equipment and loading systems; and power tools and lifting equipment, including associated aftermarket parts, consumables, air treatment equipment, controls, other accessories, and services. The Precision and Science Technologies segment designs, manufactures, and markets a range of specialized positive displacement pumps, fluid management systems, accessories and aftermarket parts for liquid and gas dosing, transfer, dispensing, compression, sampling, pressure management and flow control in specialized or critical applications. The company's products are used in medical, laboratory, industrial manufacturing, water and wastewater, chemical processing, precision irrigation, energy, food and beverage, agriculture, and vacuum and automated liquid handling end-markets, as well as various manufacturing and industrial facilities applications. It sells through an integrated network of direct sales representatives and independent distributors under the Ingersoll Rand, Gardner Denver, Club Car, CompAir, Nash, Elmo Rietschle, Robuschi, Thomas, Milton Roy, Seepex, ARO, Emco Wheaton, Runtech Systems, Air Dimensions, Albin, Dosatron, Haskel, LMI, Maximus, MP, Oberdorfer, Welch, Williams, Zinnser Analytic, and YZ brands. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is headquartered in Davidson, North Carolina.
How the Company Makes MoneyIngersoll Rand generates revenue through the sale of its diverse range of products and services, primarily focusing on industrial equipment and climate solutions. The company's revenue model is driven by both product sales and recurring service contracts, which include maintenance, repair, and parts sales for their machinery. A significant portion of their earnings comes from aftermarket services, which provide ongoing support and enhancements for their installed base of equipment. Additionally, Ingersoll Rand benefits from strategic partnerships with various industrial sectors, enhancing their market reach and capabilities. Their commitment to sustainability and innovation allows them to capture new market opportunities, contributing positively to their overall earnings.

Ingersoll Rand Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Shows how much each business unit contributes to total sales, indicating which segments are growing and which may need strategic adjustments.
Chart InsightsIngersoll Rand's Industrial Technologies and Services segment shows steady growth, but recent quarters reveal volatility, likely due to tariff impacts and delayed pricing actions. Precision and Science Technologies (PST) is gaining momentum, driven by strong order growth and strategic M&A, despite tariff challenges. The Specialty Vehicle and High Pressure Solutions segments remain inactive. The company's strategic focus on M&A and innovative product launches, like the META Contact Cool Compressor, aims to sustain growth and mitigate current headwinds, with long-term margin targets in sight.
Data provided by:The Fly

Ingersoll Rand Earnings Call Summary

Earnings Call Date:Feb 12, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 06, 2026
Earnings Call Sentiment Positive
The call reflected solid financial and operational performance: strong adjusted EBITDA, EPS growth, robust M&A execution, accelerating recurring revenue, and healthy liquidity and capital returns. Management acknowledged margin headwinds from tariffs and strategic reinvestments, a modest full-year organic revenue contraction in 2025, Q4 seasonality with book-to-bill below one, and cautious 2026 guidance that does not assume a market recovery. The balance of positive execution, cash generation, and a deep and disciplined M&A pipeline outweighs the near-term headwinds and conservative assumptions.
Q4-2025 Updates
Positive Updates
Quarterly Orders and Revenue Growth
Q4 orders increased 8% year-over-year (organic +1%); Q4 revenue rose 10% year-over-year (organic revenue +3%), signaling positive momentum into 2026.
Strong Adjusted EBITDA and Margins
Q4 adjusted EBITDA was $580 million with a margin of 27.7%; full-year adjusted EBITDA approximately $2.1 billion with a 27.4% margin, exceeding the upper end of prior guidance.
Earnings Per Share Improvements
Q4 adjusted EPS was $0.96 (up 14% year-over-year); full-year adjusted EPS $3.34, up 2% year-over-year; 2026 guidance of $3.45–$3.57 implies ~5% growth at the midpoint.
Recurring Revenue Acceleration
Recurring revenue exceeded $450 million in 2025 with a backlog of approximately $1.1 billion of future contracted revenue, up materially from roughly $200 million a few years prior.
Robust M&A Execution and Pipeline
Invested $525 million across 16 transactions in 2025 generating ~ $275 million in annualized inorganic revenue (average ~9x presynergy multiple); nine additional transactions currently under LOI and Synomics closed in January 2026.
Strong Capital Deployment and Balance Sheet
Deployed $1.0 billion in share repurchases and $32 million in dividends in 2025; $3.8 billion in liquidity, leverage well under 2x, Q4 cash flow $462 million.
Segment-Level Strength — PST Life Sciences
PST Q4 orders up 6% YoY (organic +1%), life sciences organic orders up mid-teens; Q4 PST revenue +8% YoY (organic +4%); PST adjusted EBITDA $127 million, up 19% YoY with a 30.4% margin (+280 bps YoY).
Regional and Product Wins, Including China
ITS Q4 orders up 9% (organic low single digits); Asia Pacific showed strong growth (APAC up low double digits, China up low single digits, rest of Asia mid-twenties); three consecutive quarters of organic growth in China attributed to localized product launches and technology integrations.
Negative Updates
Full-Year Organic Revenue Slight Decline
Full-year total revenue was up 6% YoY but organic revenue finished down 1% year-over-year, driven by tough first-half comps.
Margin Pressure from Tariffs and Reinvestment
Year-over-year margin headwinds were primarily driven by tariff impacts and intentional commercial reinvestments; ITS Q4 adjusted EBITDA margin declined to 28.9% due in part to tariff dilution and growth investments.
Quarterly Book-to-Bill Below One
Q4 book-to-bill finished below 1 for both segments (company Q4 book-to-bill 0.93 overall; PST 0.96), indicating seasonality and some shipment timing pressure in the quarter.
Conservative 2026 Organic Assumptions
2026 guidance embeds modest organic order growth (1% at midpoint) and explicitly does not assume a market inflection — guidance assumes essentially current trajectory without recovery baked in.
Elongated Decision-Making in Long-Cycle Projects
Management noted continued elongation in customer decision timelines for long-cycle projects (delays rather than cancellations), which can slow conversion even with a healthy funnel.
Regional Variability — EMEA Softness in Q4
ITS Q4 organic orders in EMEA were down mid single digits (attributed to project timing) despite positive full-year results, highlighting regional unevenness.
Working Capital/Inventory Impact from Tariffs
Tariff-related dynamics led to inventory build that continues to pressure working capital; management identified inventory and working capital efficiency as a key area to improve FCF conversion.
Company Guidance
Ingersoll Rand guided full‑year 2026 revenue growth of 2.5%–4.5%, driven at the midpoint by ~1% organic growth, ~1.5% from M&A (including 2025 carryover and the Synomics deal) and a ~1% FX tailwind, with total adjusted EBITDA of $2.13–$2.19 billion and corporate costs planned at $170 million (evenly incurred). Adjusted EPS is expected to be $3.45–$3.57 (about 5% growth at the midpoint) with an adjusted tax rate of ~23%, net interest of ~ $230 million, share count of ~394 million, and free cash‑flow to adjusted‑net‑income conversion of ~95%; management said the guide assumes no market recovery (phasing consistent with historical seasonality: Q1 organic flat to slightly down, Q2–Q4 low single‑digit organic growth) and expects roughly mid‑single‑digit EPS growth in both the first and second halves.

Ingersoll Rand Financial Statement Overview

Summary
Steady revenue growth and strong operating margins (2025 EBIT ~18.5%, EBITDA ~25.1%) with durable cash generation (2025 OCF ~$1.36B; FCF ~$1.22B). Offsetting this, 2025 net margin and net income fell versus 2024, ROE declined (~5.8%), and leverage has increased versus 2022–2023, indicating some deterioration in earnings efficiency and balance-sheet conservatism.
Income Statement
74
Positive
Revenue has grown steadily from 2021–2025 (2025 revenue up ~2.6% YoY), and operating profitability has improved meaningfully versus 2020, with 2025 EBIT margin around 18.5% and EBITDA margin ~25.1%. However, profitability softened in 2025 versus 2024: net margin fell to ~7.6% from ~11.6%, and net income declined despite higher revenue, pointing to weaker below-the-line performance. Overall: solid operating engine with a recent step-down in net earnings quality.
Balance Sheet
71
Positive
Leverage is moderate with 2025 debt-to-equity at ~0.47, but it has risen versus 2022–2023 (low ~0.28 in 2023) as total debt increased sharply into 2024–2025. Equity remains sizable (~$10.1B in 2025) supporting the capital structure, yet returns on equity have drifted down to ~5.8% in 2025 from ~8.2% in 2024, consistent with the earnings decline. Overall: generally sound balance sheet with a noticeable recent uptick in leverage and lower shareholder returns.
Cash Flow
73
Positive
Cash generation is strong and consistent: 2025 operating cash flow (~$1.36B) and free cash flow (~$1.22B) remain healthy, and free cash flow has closely tracked reported earnings (around ~0.90x net income in 2024–2025). The main weakness is momentum—free cash flow growth turned slightly negative in 2024 and declined further in 2025—suggesting a plateau after earlier expansion. Overall: solid cash conversion with slowing growth.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue7.65B7.24B6.88B5.92B5.15B
Gross Profit2.95B3.17B2.88B2.33B1.99B
EBITDA1.92B1.83B1.65B1.28B1.02B
Net Income581.40M838.60M778.70M604.70M562.50M
Balance Sheet
Total Assets18.30B18.01B15.56B14.77B15.15B
Cash, Cash Equivalents and Short-Term Investments1.25B1.54B1.60B1.61B2.11B
Total Debt4.78B4.98B2.77B2.79B3.48B
Total Liabilities8.14B7.76B5.72B5.51B6.08B
Stockholders Equity10.09B10.18B9.78B9.20B9.00B
Cash Flow
Free Cash Flow1.22B1.25B1.27B765.70M551.40M
Operating Cash Flow1.36B1.40B1.38B860.30M615.50M
Investing Cash Flow-660.60M-3.11B-1.06B-332.90M914.30M
Financing Cash Flow-1.05B1.71B-337.50M-954.00M-1.16B

Ingersoll Rand Technical Analysis

Technical Analysis Sentiment
Positive
Last Price93.94
Price Trends
50DMA
87.30
Positive
100DMA
82.90
Positive
200DMA
82.46
Positive
Market Momentum
MACD
2.74
Positive
RSI
53.35
Neutral
STOCH
19.26
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IR, the sentiment is Positive. The current price of 93.94 is above the 20-day moving average (MA) of 93.76, above the 50-day MA of 87.30, and above the 200-day MA of 82.46, indicating a bullish trend. The MACD of 2.74 indicates Positive momentum. The RSI at 53.35 is Neutral, neither overbought nor oversold. The STOCH value of 19.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IR.

Ingersoll Rand Risk Analysis

Ingersoll Rand disclosed 30 risk factors in its most recent earnings report. Ingersoll Rand reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Ingersoll Rand Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$53.65B36.6114.59%0.59%3.67%10.44%
75
Outperform
$31.30B29.2315.29%1.04%-5.24%45.69%
70
Outperform
$38.07B67.045.35%0.10%4.20%-34.47%
68
Neutral
$16.66B25.7017.48%0.96%0.83%-1.32%
68
Neutral
$44.55B45.3627.71%1.33%0.98%-7.51%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
$14.50B52.014.27%0.97%-4.99%22.16%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IR
Ingersoll Rand
93.94
10.63
12.76%
AME
Ametek
231.45
45.75
24.64%
DOV
Dover
230.73
34.57
17.62%
PNR
Pentair
101.66
9.27
10.03%
RRX
Regal Rexnord
218.21
86.08
65.15%
ROK
Rockwell Automation
387.63
103.24
36.30%

Ingersoll Rand Corporate Events

Business Operations and StrategyExecutive/Board Changes
Ingersoll Rand Appoints Jerome Guillen to Board
Positive
Dec 17, 2025

On December 17, 2025, Ingersoll Rand announced the appointment of Jerome Guillen to its Board of Directors, effective January 1, 2026. Guillen, formerly a Tesla executive with extensive experience in innovation, engineering, and operational leadership across various sectors, will contribute to the company’s sustainability and growth. The move reflects Ingersoll Rand’s strategic commitment to fostering innovation and operational excellence, signaling its intent to strengthen its industry position and deliver cutting-edge solutions to stakeholders.

The most recent analyst rating on (IR) stock is a Hold with a $81.00 price target. To see the full list of analyst forecasts on Ingersoll Rand stock, see the IR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 14, 2026